Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Daventry Group, LP

Q4 2023 · 13F-HR

Daventry Group, LPholdings as filed

Filed 2024-02-13 · accession 0001172661-24-000827

$232.9M
Reported value
9
Positions
2023-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
88025T102TENBTENABLE HLDGS INC$43.1M18.5%936,576CommonSOLE
69370C100PTCPTC INC$35.9M15.4%205,051CommonSOLE
N14506104ESTCELASTIC N V$35.8M15.4%317,647CommonSOLE
418100103HCP2EURHASHICORP INC$27.0M11.6%1,144,036CommonSOLE
159864107CRLCHARLES RIV LABS INTL INC$26.3M11.3%111,162CommonSOLE
29978A104EVBGEUREVERBRIDGE INC$19.0M8.14%780,262CommonSOLE
00857U107AGILON HEALTH INC$18.9M8.13%1,508,432CommonSOLE
42225T107HCATHEALTH CATALYST INC$17.8M7.64%1,920,375CommonSOLE
15687V109CERTCERTARA INC$9.1M3.91%517,167CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.